Bias toward allopathic medicine in the research funding and publication of study results makes it difficult for physicians and others to find accurate data about the efficacy of non-Western, nonallopathic treatments.
Industry sponsorship of continuing medical education is controversial. A standard to adhere to is that before accepting any industry-sponsored education or incentive, a physician should form an independent evaluation of the product.
Clinical trials for the blood substitute PolyHeme exposed the possibility for ambiguous interpretation of the FDA’s waiver of informed consent for emergency research.
A case that illustrates how Western medicine's body or mind approach to diagnosis and treatment can differ from that of many patients from non-Western cultures.